2302-25-2

应用筛选条件

关键词:'2302-25-2'

显示 1-2 共 2 条结果关于 "2302-25-2" 范围论文

Clinical characteristics and molecular analysis of three Chinese children with Omenn syndrome.

Zhi-Yong Zhang et al.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 22(5), 482-487 (2011-07-21)

Omenn syndrome (OS) is a rare autosomal recessive genetic disorder and presents symptoms of severe combined immunodeficiency characterized by erythrodermia, eosinophilia, hepatosplenomegaly, lymphadenopathy, and elevated serum IgE levels. OS has been found to be caused by mutations in RAG1 or

Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study.

David F Heigener et al.

Lung cancer (Amsterdam, Netherlands), 74(2), 274-279 (2011-03-29)

Erlotinib is a highly potent inhibitor of epidermal growth factor receptor tyrosine-kinase activity that significantly prolongs overall survival in patients with non-small-cell lung cancer (NSCLC), and improves symptom control and quality of life compared with placebo. The safety and efficacy

1/1